Tandem Diabetes Care (TNDM) Share-based Compensation (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Share-based Compensation data on file, last reported at $15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 38.56% year-over-year to $15.7 million; the trailing twelve-month figure through Mar 2026 stood at $82.6 million (down 21.25% YoY), and the FY2025 full-year result was $92.4 million, down 8.88% from the prior year.
• Share-based Compensation for Q1 2026 stood at $15.7 million, down from $20.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $28.2 million in Q4 2024 and bottomed at $15.7 million in Q1 2026.
• The 5-year median for Share-based Compensation is $22.2 million (2022), against an average of $22.5 million.
• The widest annual swing landed in 2022, when Share-based Compensation surged 42.94%; it then slumped 38.56% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $24.4 million in 2022, then fell by 6.96% to $22.7 million in 2023, then climbed by 23.86% to $28.2 million in 2024, then slipped by 28.6% to $20.1 million in 2025, then fell by 22.13% to $15.7 million in 2026.
• The last three Share-based Compensation figures came in at $15.7 million (Q1 2026), $20.1 million (Q4 2025), and $21.1 million (Q3 2025), per Business Quant data.

Peer Comparison